Yahoo Web Search

Search results

1. • ...Phase 3 Clinical Trial in Treating Moderate to Severe Plaque Psoriasis, and Plans to Submit NDA...

     WRBL Columbus· 2 days ago

     CLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of subjects...

2. • 

     Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial

     Clinical Trials Arena via Yahoo Finance· 2 days ago

     “We will actively prepare to submit the new drug application of picankibart based on the CLEAR-1...

3. • 

     Zai Lab doses first subject in Phase II plaque psoriasis treatment trial

     Clinical Trials Arena via Yahoo Finance· 6 days ago

     "Zai Lab doses first subject in Phase II plaque psoriasis treatment trial" was originally created...

4. • 

     Innovent to take IL-23 psoriasis drug to Chinese regulators after phase 3 win

     FierceBiotech· 1 day ago

     The anti-IL-23 monoclonal antibody, called picankibart, hit all primary and key secondary endpoints...

5. • 

     Why Mindy Kaling Is Advocating for a Health Condition She Doesn't Have

     SheKnows· 1 day ago

     Mindy Kaling is no stranger to advocating for herself. Before she created hit shows like The Mindy...

6. • 

     10 Science-Backed Benefits of Turmeric for Skin

     Prevention via Yahoo News· 2 hours ago

     In a separate study, blue light and curcumin were found to be an effective treatment of skin infections like MRSA in mice. It has been found to aid in ...

7. • 

     Ladenburg says Buy Palisade Bio stock, sees potential in PALI-2108 By Investing.com

     Investing.com· 11 hours ago

     Ladenburg says Buy Palisade Bio stock, sees potential in PALI-2108

8. • AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review

     ETF DAILY NEWS· 5 days ago

     AbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...

9. • UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...

     WKRN Nashville· 7 days ago

     In these studies, bimekizumab consistently demonstrated sustained improvements...

10. • 

      7 Biotech Stocks to Put on Your Breakthrough Radar

      InvestorPlace· 2 days ago

      For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....